Sanofi to open R&D hub in China

Jul 02, 2018

 Sanofi announced plans to launch a Global R&D Operations Hub with a specialized focus on digitalization and big data analysis in Chengdu, Sichuan province, China.

The $77 million hub will support the clinical research and development of Sanofi's innovative drugs by focusing on the management of global multi-center clinical trials data and files.

Sanofi says the Hub will target diseases such as diabetes and cardiovascular diseases, vaccines, oncology, immunology and inflammation, rare diseases, multiple sclerosis and neurology. It will leverage global cutting-edge biological technology for polypeptides, gene therapy, monoclonal antibodies and multi-specific antibodies.

The drugmaker plans to recruit 300 local pharmaceutical research and development professionals by 2020.

Read the press release